|
1
|
Garland SM, Tobin JM, Pirotta M, et al:
The ProPrems trial: investigating the effects of probiotics on late
onset sepsis in very preterm infants. BMC Infect Dis. 11:210–215.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu P, Sodhi CP and Hackam DJ: Toll-like
receptor regulation of intestinal development and inflammation in
the pathogenesis of necrotizing enterocolitis. Pathophysiology.
21:81–93. 2014. View Article : Google Scholar :
|
|
3
|
Kim SY, Koo JE, Seo YJ, et al: Suppression
of Toll-like receptor 4 activation by caffeic acid phenethyl ester
is mediated by interference of LPS binding to MD2. Br J Pharmacol.
168:1933–1945. 2013. View Article : Google Scholar :
|
|
4
|
Shibata T, Motoi Y, Tanimura N, et al:
Intracellular TLR4/MD-2 in macrophages senses Gram-negative
bacteria and induces a unique set of LPS-dependent genes. Int
Immunol. 23:503–510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akashi S, Saitoh S, Wakabayashi Y, et al:
Lipopolysaccharide interaction with cell surface Toll-like receptor
4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med.
198:1035–1042. 2013. View Article : Google Scholar
|
|
6
|
Zeng L, Zhang AQ, Gu W, et al:
Identification of haplotype tag SNPs within the whole myeloid
differentiation 2 gene and their clinical relevance in patients
with major trauma. Shock. 37:366–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu W, Shan YA, Zhou J, et al: Functional
significance of gene polymorphisms in the promoter of myeloid
differentiation-2. Ann Surg. 246:151–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wright CS, Mi LZ, Lee S and Rastinejad F:
Crystal structure analysis of phosphatidylcholine-GM2-activator
product complexes: evidence for hydrolase activity. Biochemistry.
44:13510–13521. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Caplan MS, Simon D and Jilling T: The role
of PAF, TLR and the inflammatory response in neonatal necrotizing
enterocolitis. Semin Pediatr Surg. 14:145–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frost BL and Caplan MS: Necrotizing
enterocolitis: pathophysiology, platelet-activating factor and
probiotics. Semin Pediatr Surg. 22:88–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chan KL, Wong KF and Luk JM: Role of
LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis:
pathogenesis and therapeutic implications. World J Gastroenterol.
15:4745–4752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rigat B, Yeger H, Shehnaz D and Mahuran D:
GM2 activator protein inhibits platelet activating factor signaling
in rats. Biochem Biophys Res Commun. 385:576–580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hackam DJ, Good M and Sodhi CP: Mechanisms
of gut barrier failure in the pathogenesis of necrotizing
enterocolitis: Toll-like receptors throw the switch. Semin Pediatr
Surg. 22:76–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jain L: Necrotizing enterocolitis
prevention: art or science? Clin Perinatol. 40:xiii–xv. 2013.
|
|
15
|
Bhandari V, Bizzarro MJ, Shetty A, et al:
Familial and genetic susceptibility to major neonatal morbidities
in preterm twins. Pediatrics. 117:1901–1906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prencipe G, Azzari C, Moriondo M, et al:
Association between mannose-binding lectin gene polymorphisms and
necrotizing enterocolitis in preterm infants. J Pediatr
Gastroenterol Nutr. 55:160–165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Visintin A, Iliev DB, Monks BG, et al:
Md-2. Immunobiology. 211:437–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu W, Shan YA, Liu Q, et al: Relationship
of myeloid differentiation-2 gene promoter polymorphisms with
susceptivity of complications after severe trauma in Chinese Han
population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 29:484–487.
2007.In Chinese. PubMed/NCBI
|
|
19
|
Hamann L, Kumpf O, Muller M, et al: A
coding mutation within the first exon of the human MD-2 gene
results in decreased lipopolysac-charide-induced signaling. Genes
Immun. 5:283–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vasl J, Prohinar P, Gioannini TL, et al:
Functional activity of MD-2 polymorphic variant is significantly
different in soluble and TLR4-bound forms: decreased endotoxin
binding by G56R MD-2 and its rescue by TLR4 ectodomain. J Immunol.
180:6107–6115. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Izumi T and Shimizu T: Platelet-activating
factor receptor: gene expression and signal transduction. Biochim
Biophys Acta. 1259:317–333. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Caplan MS, Sun XM, Hseuh W and Hageman JR:
Role of platelet activating factor and tumor necrosis factor-alpha
in neonatal necrotizing enterocolitis. J Pediatr. 116:960–964.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Caplan M, Hsueh W, Kelly A and Donovan M:
Serum PAF acetylhydrolase increases during neonatal maturation.
Prostaglandins. 39:705–714. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Soliman A, Michelsen KS, Karahashi H, et
al: Platelet-activating factor induces TLR4 expression in
intestinal epithelial cells: implication for the pathogenesis of
necrotizing enterocolitis. PLoS One. 5:e150442010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rigat B, Reynaud D, Smiljanic-Georgijev N
and Mahuran D: The GM2 activator protein, a novel inhibitor of
platelet-activating factor. Biochem Biophys Res Commun.
258:256–259. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimada Y, Li YT and Li SC: Effect of GM2
activator protein on the enzymatic hydrolysis of phospholipids and
sphingomyelin. J Lipid Res. 44:342–348. 2003. View Article : Google Scholar : PubMed/NCBI
|
